A gonadotropin-releasing hormone agonist versus a continuous oral contraceptive pill in the treatment of bladder endometriosis.
A prospective comparative clinical trial was done in a tertiary referral center for the treatment of endometriosis in 10 patients with bladder detrusor endometriosis: five were treated with a continuous oral contraceptive (OC) and another five with a GnRH agonist. Continuous OC therapy may be effective in the short-term treatment of bladder endometriosis.
Fedele
Luigi
L
Clinica Ostetrica e Ginecologica II, Università di Milano, Fondazione Policlinico Mangiagalli e Regina Elena, Milan, Italy. luigi.fedele@unimi.it
Bianchi
Stefano
S
Montefusco
Sarah
S
Frontino
Giada
G
Carmignani
Luca
L
D003276:Contraceptives, Oral / Q000627:therapeutic use*; D004715:Endometriosis / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists*; D006801:Humans; D011446:Prospective Studies; D013997:Time Factors; D016896:Treatment Outcome; D001743:Urinary Bladder / Q000187:drug effects* / Q000473:pathology; D001745:Urinary Bladder Diseases / Q000188:drug therapy* / Q000473:pathology
D003276:Contraceptives, Oral; D007987:Gonadotropin-Releasing Hormone